Copyright © 2000 by the European Society of Cardiology.
Editorial
Should we transfer patients with acute myocarial infarcation to a tertiary care hospital for primary angioplasty?
Gasthuisberg University Hospital, Leuven, Belgium
References
- Weaver WD, Simes RJ, Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:20932098
[Abstract/Free Full Text] - Widimský P, Groch L,
elizko M, Aschermann M, Bedná
F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without catheterization. Eur Heart J. 2000;21:823831[Abstract/Free Full Text] - Ross AM. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol. 1999;34:19541962
[Abstract/Free Full Text] - Gurbel PA, Serebruany VL, Shustov AR. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. J Am Coll Cardiol. 1998;31:14661473
[Abstract/Free Full Text] - Antman E, Giugliano RP, Gibson MC. Abciximab facilitates the rate and extent of thrombolysis. Results of the TIMI 14 trial. Circulation. 1999;99:27202732
[Abstract/Free Full Text] - Topol, EJ, The SPEED trial, presented at the XXIst Congress of the European Society of Cardiology, Barcelona, 1999
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||